Medical affairs

Patients

There is a strong emphasis on patient centricity, but, in many cases, patient engagement is just used to validate pre-existing assumptions.

Digital

The shift that matters is not about replacing the MSL's judgement. It is about removing the friction around it.

R&D

LUCENT Biopharma's Medical Director Matthew Goodman, a doctor by training, specialises in late-phase Clinical Development and Medical Affairs.

Digital

Explore an AI-powered 360 Medical Engagement vision that links engagement, insight, evidence, and strategy in a continuous loop.

Sales & Marketing

Sales & Marketing

To stay relevant, medical affairs teams must adapt how they work to meet new demands with greater agility and efficiency.